TrialBlood advances2026

Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults.

Yan Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.